Redir

Monday, May 2, 2011

Gene that mediates response to key cancer drugs frequently mutated in young leukemia patients who relapse

The effort led by St. Jude Children’s Research Hospital scientists identified the gene as a potential marker of relapse risk and involved the most comprehensive search yet for genomic changes in relapsed childhood acute lymphoblastic leukemia
Read More...
[Source: St. Jude Children's Research Hospital - Latest News]

No comments:

Post a Comment